Ascendis Pharma A/S Trade And Other Current Payables To Trade Suppliers
Ascendis Pharma A/S (ASND) had Trade And Other Current Payables To Trade Suppliers of EUR 90.66 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers · last filed 2026-02-11
- 2025-12-31: Trade And Other Current Payables To Trade Suppliers 90.66M EUR.
- 2025-09-30: Trade And Other Current Payables To Trade Suppliers 78.60M EUR.
- 2025-06-30: Trade And Other Current Payables To Trade Suppliers 93.72M EUR.
- 2025-03-31: Trade And Other Current Payables To Trade Suppliers 84.37M EUR.
| Period end | Trade And Other Current Payables To Trade Suppliers |
|---|---|
| 2025-12-31 | 90.66M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 78.60M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 93.72M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 84.37M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 96.39M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 75.27M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 99.53M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 94.53M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 94.57M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 121.55M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 122.12M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 131.44M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 101.03M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 101.03M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 86.10M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 74.98M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 70.68M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 59.42M EUR 20-F · filed 2023-02-16 |
| 2021-09-30 | 76.47M EUR 6-K · filed 2021-11-10 |
| 2021-06-30 | 44.21M EUR 6-K · filed 2021-08-27 |
| 2021-03-31 | 54.13M EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 21.90M EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 38.11M EUR 6-K · filed 2020-11-12 |
| 2020-06-30 | 31.57M EUR 6-K · filed 2020-08-27 |
| 2020-03-31 | 27.28M EUR 6-K · filed 2020-05-19 |
| 2019-12-31 | 27.77M EUR 20-F · filed 2021-03-10 |
| 2019-09-30 | 24.35M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 21.23M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 19.24M EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 19.74M EUR 20-F · filed 2020-04-03 |
| 2017-12-31 | 17.43M EUR 20-F · filed 2019-04-03 |